Loading...
Market
What percentage of global cholera cases will be covered by Bharat Biotech's new vaccine by December 31, 2025?
2
Resolution / Starting Odds
Less than 10% • 25%
10-20% • 25%
20-30% • 25%
More than 30% • 25%
Global health reports and statistics from WHO and other health organizations
Story
Bharat Biotech Launches Oral Cholera Vaccine After Successful Trials
Aug 27, 2024, 07:50 AM
Bharat Biotech, an Indian vaccine manufacturer, has launched a next-generation oral cholera vaccine following successful phase 3 trials. The trials demonstrated that the vaccine is safe for public use. This development aims to address the rising global cholera cases and deaths, which have been increasing steadily since 2021. From early 2023 to March 2024, there have been 824,479 reported cases and 5,900 deaths across 31 countries. The new vaccine is expected to help bridge the global gap in cholera prevention and treatment.
View original story
Similar markets
Yes • 50%
No • 50%
Less than 20% • 25%
20% to 40% • 25%
40% to 60% • 25%
More than 60% • 25%
Less than 50% • 25%
50% to 70% • 25%
70% to 90% • 25%
More than 90% • 25%
Less than 25% • 25%
25% to 50% • 25%
51% to 75% • 25%
More than 75% • 25%
0-10 million doses • 25%
10-20 million doses • 25%
20-30 million doses • 25%
30+ million doses • 25%
0-10 countries • 25%
11-20 countries • 25%
21-30 countries • 25%
31+ countries • 25%
Below 70% • 25%
70% to 79% • 25%
80% to 89% • 25%
90% or above • 25%
Less than 10% • 25%
10% to 20% • 25%
20% to 30% • 25%
More than 30% • 25%
Less than 50% • 25%
50% - 70% • 25%
71% - 90% • 25%
More than 90% • 25%
Less than 5% • 25%
5% to 10% • 25%
10% to 20% • 25%
More than 20% • 25%
Less than 50% • 25%
50% - 75% • 25%
75% - 90% • 25%
More than 90% • 25%